Investigating how Tau affects the parathyroid gland in older adults with hyperparathyroidism
Official title: The role of Tau in mediating the effects of abeta(1-42) on the parathyroid gland in primary hyperparathyroidism
Funded at University of California, San Francisco · NIH-11193152 · Data updated 2026-11-12
This study is looking at how certain proteins and vitamin D levels affect the parathyroid glands in older adults with primary hyperparathyroidism, to help us understand better how this condition can lead to problems like weak bones and a higher chance of falling.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | April 15, 2023 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $147,918 |
| NIH project number | 3RF1AG075742-01A1S1 |
| Project ID | NIH-11193152 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are elderly individuals diagnosed with primary hyperparathyroidism, particularly those with low vitamin D levels.
✕Less likely to help
Patients who are not elderly or do not have hyperparathyroidism may not benefit from this research.
What this research studies
This research explores the relationship between Tau protein and the effects of amyloid beta on the parathyroid gland, particularly in older adults suffering from primary hyperparathyroidism. It aims to understand how vitamin D deficiency and its receptor signaling impact calcium regulation and hormone secretion in the parathyroid glands. By examining these mechanisms, the study seeks to uncover new insights into the causes and consequences of hyperparathyroidism, which can lead to serious health issues like bone loss and increased fall risk.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for hyperparathyroidism, enhancing the quality of life for older patients.
How similar studies have gone: While the specific approach of this research is novel, previous studies have shown that understanding the role of vitamin D in parathyroid function can lead to significant insights in related conditions.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Koh, James — University of California, San Francisco
- Study coordinator: Koh, James
Related research
Other NIH-funded projects on the same topics.
-
Understanding cognitive issues in older adults with high parathyroid hormone levels
This study looks at how primary hyperparathyroidism might affect memory and thinking skills in older adults aged 65 and up, helping to show why it's important to diagnose and treat this condition for better brain health and overall quality of life.
-
Understanding parathyroid tumors in primary hyperparathyroidism
This study is looking at the genes and features of parathyroid tumors in people with primary hyperparathyroidism to find clues that can help doctors tell if the problem is in one gland or multiple glands, which could lead to better, more tailored treatments for you.
-
Role of LH and hCG in adults being evaluated for endocrine disorders
This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.
-
NIRAF imaging to help parathyroid removal when preoperative tests don’t locate glands
This trial tests whether using an NIRAF camera during parathyroid surgery helps find and remove abnormal glands in people with primary hyperparathyroidism when prior imaging hasn’t pinpointed them.
-
18F‑Fluorocholine PET/MRI and NeuroEXPLORER PET/CT to locate parathyroid tumors
This trial will test whether 18F‑Fluorocholine PET/MRI and NeuroEXPLORER PET/CT scans can better find overactive or cancerous parathyroid glands in adults scheduled for surgery.
-
Amino acid transporter PET/CT imaging with MET/FET for AATS-related tumors
This project tries PET/CT scans using 11C- or 18F-labeled MET/FET tracers to see if they better find primary or metastatic lesions in adults with amino acid transporter–related tumors such as glioma and primary hyperparathyroidism.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.